Scholars Central

Mini reviewPublished 28 Jun 2024

Discovery of New Autotaxin Inhibitors Using Structure-based Approaches

Authors: Meihui Nelson

Journal of Clinical Research

Volume 8 · Issue 3 · Pages 1–2

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The discovery of effective AutoTaXin (ATX) inhibitors is crucial for developing therapies targeting various diseases, including cancer, inflammation and fibrosis. Structure-based drug design has emerged as a powerful strategy to identify and optimize ATX inhibitors with enhanced potency and selectivity. This comprehensive review explores recent advancements in structure-based approaches for discovering ATX inhibitors, encompassing computational modeling, structural biology insights and medicinal chemistry strategies. Key findings highlight successful examples of ATX inhibitor development, including structure-activity relationship studies and mechanism-based drug design. The review discusses challenges, opportunities and future directions in leveraging structure-based approaches to accelerate the discovery of next-generation ATX inhibitors for clinical applications.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Clinical Research.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Clinical Research
  • SubjectGeneral & Internal Medicine
  • BylineArticles whose byline prints “Meihui Nelson”